PILA — Pila Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK74.23m
- SEK70.98m
- SEK1.13m
Brief: Pila Pharma Gets EMA Approval To Conduct PP-Ct04 Trial
Brief: Pila Pharma Announces Outcome Of To2 Option Redemption
Brief: Pila Pharma H2 EBIT Loss Narrows To SEK 3.8 Mln
Brief: Pila Pharma Determines Price For Warrants Of Series TO2
Brief: Pila Pharma Signs With New Clinical Cro
Brief: Pila Pharma H1 EBIT Loss SEK 4.1 Mln
Brief: Pila Pharma Announces Outcome Of Oversubscribed Rights Issue
Brief: Pila Pharma To Carry Out Rights Issue Of About SEK 20 Mln
Brief: Pila Pharma H2 Oper Income At SEK 0.1 Mln
Brief: Pila Pharma Achieves Preclinical Proof-Of-Concept In Cardiovascular Study
Brief: Hampus Darrell Is Pila Pharma New CFO
Sponsorship Of Preclinical Research Collaboration In Cardiovascular Disease
Brief: Pila Pharma H1 EBIT Loss Widens To SEK 4.1 Mln
Brief: Pila Pharma Completes Directed Issue
Brief: Pila Pharma To Carry Out Directed Issue Of Shares Of About SEK 10.0 Mln
Brief: Pila Pharma Appoints New Chairman Of Board And CEO
Brief: Pila Pharma Q4 Operating Loss Narrows To SEK 1.3 Mln
Brief: Pila Pharma Raises SEK 8.1 Mln In Right Issue
Brief: Pila Pharma Q3 Operating Result Breaks Even